Suivre
A. T. Cohen
A. T. Cohen
Consultant Vascular Physician, Guy's and St Thomas' Hospitals NHS Foundation Trust
Adresse e-mail validée de KCL.AC.UK
Titre
Citée par
Citée par
Année
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
Einstein–PE Investigators
New England journal of medicine 366 (14), 1287-1297, 2012
29382012
Oral apixaban for the treatment of acute venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, ...
New England Journal of Medicine 369 (9), 799-808, 2013
28692013
Venous thromboembolism (VTE) in Europe
AT Cohen, G Agnelli, FA Anderson, JI Arcelus, D Bergqvist, JG Brecht, ...
Thrombosis and haemostasis 98 (10), 756-764, 2007
24622007
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, ...
New England Journal of Medicine 341 (11), 793-800, 1999
21961999
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
AT Cohen, VF Tapson, JF Bergmann, SZ Goldhaber, AK Kakkar, ...
The lancet 371 (9610), 387-394, 2008
19762008
Apixaban for extended treatment of venous thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus, M Johnson, A Porcari, ...
New England Journal of Medicine 368 (8), 699-708, 2013
17302013
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer
D Bergqvist, G Agnelli, AT Cohen, A Eldor, PE Nilsson, ...
New England Journal of Medicine 346 (13), 975-980, 2002
14292002
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz, AT Cohen, AGG Turpie, CG Olsson, PT Vaitkus, ...
Circulation 110 (7), 874-879, 2004
12562004
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial
AT Cohen, BL Davidson, AS Gallus, MR Lassen, MH Prins, W Tomkowski, ...
Bmj 332 (7537), 325-329, 2006
10892006
Apixaban for the treatment of venous thromboembolism associated with cancer
G Agnelli, C Becattini, G Meyer, A Muñoz, MV Huisman, JM Connors, ...
New England Journal of Medicine 382 (17), 1599-1607, 2020
10022020
Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
SJ Connolly, TJ Milling Jr, JW Eikelboom, CM Gibson, JT Curnutte, A Gold, ...
New England Journal of Medicine 375 (12), 1131-1141, 2016
9742016
Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors
SJ Connolly, M Crowther, JW Eikelboom, CM Gibson, JT Curnutte, ...
New England Journal of Medicine 380 (14), 1326-1335, 2019
9542019
Rivaroxaban or aspirin for extended treatment of venous thromboembolism
JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ...
New England Journal of Medicine 376 (13), 1211-1222, 2017
8552017
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
New England Journal of Medicine 368 (6), 513-523, 2013
7562013
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, ...
Archives of internal medicine 164 (9), 963-968, 2004
7282004
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
MH Prins, AWA Lensing, R Bauersachs, B Van Bellen, H Bounameaux, ...
Thrombosis journal 11, 1-10, 2013
6782013
Gemini 1.5: Unlocking multimodal understanding across millions of tokens of context
G Team, P Georgiev, VI Lei, R Burnell, L Bai, A Gulati, G Tanzer, ...
arXiv preprint arXiv:2403.05530, 2024
6762024
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin along among 41 299 cases of suspected …
D Hunt, J Varigos, F Dienstl, P Lechleitner, G De Backer, M Kornitzer, ...
Lancet 339 (8796), 753-770, 1992
6151992
Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US.
JA Heit, AT Cohen, FA Anderson Jr
Blood 106 (11), 910, 2005
544*2005
Extended thromboprophylaxis with betrixaban in acutely ill medical patients
AT Cohen, RA Harrington, SZ Goldhaber, RD Hull, BL Wiens, A Gold, ...
New England Journal of Medicine 375 (6), 534-544, 2016
5222016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20